NYSE:TMO - Thermo Fisher Scientific Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$214.94 +3.93 (+1.86 %)
(As of 05/20/2018 04:00 PM ET)
Previous Close$214.94
Today's Range$211.22 - $215.47
52-Week Range$170.07 - $226.44
Volume1.07 million shs
Average Volume1.49 million shs
Market Capitalization$86.48 billion
P/E Ratio22.65
Dividend Yield0.32%
Beta1.14

About Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNYSE:TMO
CUSIP88355610
Phone781-622-1000

Debt

Debt-to-Equity Ratio0.69
Current Ratio1.36
Quick Ratio0.95

Price-To-Earnings

Trailing P/E Ratio22.65
Forward P/E Ratio19.70
P/E Growth1.58

Sales & Book Value

Annual Sales$20.92 billion
Price / Sales4.13
Cash Flow$14.4838 per share
Price / Cash14.84
Book Value$64.93 per share
Price / Book3.31

Profitability

EPS (Most Recent Fiscal Year)$9.49
Net Income$2.23 billion
Net Margins10.24%
Return on Equity16.09%
Return on Assets7.35%

Miscellaneous

Employees70,000
Outstanding Shares402,320,000

Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Wednesday, January 31st. Shareholders of record on Thursday, March 15th will be given a dividend of $0.17 per share on Monday, April 16th. This represents a $0.68 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend is Wednesday, March 14th. This is a positive change from Thermo Fisher Scientific's previous quarterly dividend of $0.15. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific (NYSE:TMO) issued its quarterly earnings results on Wednesday, April, 25th. The medical research company reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.08. The medical research company earned $5.85 billion during the quarter, compared to analyst estimates of $5.62 billion. Thermo Fisher Scientific had a return on equity of 16.09% and a net margin of 10.24%. The firm's quarterly revenue was up 22.8% on a year-over-year basis. During the same period in the previous year, the firm earned $2.08 earnings per share. View Thermo Fisher Scientific's Earnings History.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Thermo Fisher Scientific.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $10.80-10.96 for the period, compared to the Thomson Reuters consensus estimate of $10.84. The company issued revenue guidance of $23.62-23.86, compared to the consensus revenue estimate of $23.62 billion.

What price target have analysts set for TMO?

14 equities research analysts have issued 12-month target prices for Thermo Fisher Scientific's shares. Their forecasts range from $195.00 to $250.00. On average, they anticipate Thermo Fisher Scientific's share price to reach $223.4167 in the next twelve months. View Analyst Ratings for Thermo Fisher Scientific.

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 50)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 51)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 55)
  • Mr. Gregory J. Herrema, Sr. VP & Pres of Customer Channels (Age 52)
  • Mr. Patrick M. Durbin, Sr. VP & Pres of Specialty Diagnostics (Age 51)

Has Thermo Fisher Scientific been receiving favorable news coverage?

Press coverage about TMO stock has been trending somewhat positive on Sunday, Accern Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Thermo Fisher Scientific earned a media sentiment score of 0.03 on Accern's scale. They also assigned press coverage about the medical research company an impact score of 47.11 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.11%), Massachusetts Financial Services Co. MA (5.77%), Northern Trust Corp (1.07%), Veritas Asset Management LLP (0.87%), Wells Fargo & Company MN (0.80%) and Dimensional Fund Advisors LP (0.64%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Which major investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Findlay Park Partners LLP, Amundi Pioneer Asset Management Inc., Sound Shore Management Inc. CT, CIBC World Markets Inc., Swiss National Bank and Caisse DE Depot ET Placement DU Quebec. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Seth H Hoogasian, Stephen Williamson and William G Parrett. View Insider Buying and Selling for Thermo Fisher Scientific.

Which major investors are buying Thermo Fisher Scientific stock?

TMO stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, BlackRock Inc., Point72 Asset Management L.P., Alleghany Corp DE, SeaTown Holdings Pte. Ltd., MUFG Securities EMEA plc, Schroder Investment Management Group and State Treasurer State of Michigan. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $214.94.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $86.48 billion and generates $20.92 billion in revenue each year. The medical research company earns $2.23 billion in net income (profit) each year or $9.49 on an earnings per share basis. Thermo Fisher Scientific employs 70,000 workers across the globe.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]


MarketBeat Community Rating for Thermo Fisher Scientific (TMO)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  540 (Vote Outperform)
Underperform Votes:  243 (Vote Underperform)
Total Votes:  783
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe TMO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Thermo Fisher Scientific (NYSE:TMO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for Thermo Fisher Scientific in the last 12 months. Their average twelve-month price target is $223.4167, suggesting that the stock has a possible upside of 3.94%. The high price target for TMO is $250.00 and the low price target for TMO is $195.00. There are currently 1 hold rating and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.932.932.932.93
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $223.4167$220.0769$220.9231$205.00
Price Target Upside: 3.94% upside2.27% upside0.07% downside6.76% upside

Thermo Fisher Scientific (NYSE:TMO) Consensus Price Target History

Price Target History for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE:TMO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$216.00 ➝ $230.00LowView Rating Details
2/1/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$235.00 ➝ $250.00LowView Rating Details
2/1/2018BarclaysBoost Price TargetOverweight ➝ Overweight$225.00 ➝ $245.00LowView Rating Details
2/1/2018Leerink SwannReiterated RatingOutperform$200.00 ➝ $239.00LowView Rating Details
1/5/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$230.00MediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform$220.00MediumView Rating Details
10/26/2017Deutsche BankSet Price TargetBuy$216.00 ➝ $226.00N/AView Rating Details
9/28/2017Jefferies GroupReiterated RatingHold$195.00LowView Rating Details
9/26/2017Goldman SachsInitiated CoverageBuy$225.00LowView Rating Details
9/10/2017CowenReiterated RatingOutperform$200.00 ➝ $220.00LowView Rating Details
8/22/2017ArgusReiterated RatingBuyMediumView Rating Details
7/20/2017Cleveland ResearchUpgradeNeutral ➝ BuyLowView Rating Details
7/13/2017Wells FargoReiterated RatingOutperform$195.00 ➝ $200.00LowView Rating Details
7/10/2017CitigroupReiterated RatingBuy$182.00 ➝ $201.00LowView Rating Details
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$194.00LowView Rating Details
9/27/2016UBSReiterated RatingBuy$176.00N/AView Rating Details
9/22/2016JPMorgan ChaseInitiated CoverageOverweight$180.00N/AView Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 ➝ $175.00N/AView Rating Details
(Data available from 5/20/2016 forward)

Earnings

Thermo Fisher Scientific (NYSE:TMO) Earnings History and Estimates Chart

Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE:TMO) Earnings Estimates

2018 EPS Consensus Estimate: $10.90
2019 EPS Consensus Estimate: $12.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$2.40$2.42$2.41
Q2 20182$2.65$2.71$2.68
Q3 20182$2.64$2.72$2.68
Q4 20182$3.10$3.15$3.13
Q1 20192$2.77$2.89$2.83
Q2 20192$2.94$2.94$2.94
Q3 20192$2.97$3.02$3.00
Q4 20192$3.24$3.38$3.31

Thermo Fisher Scientific (NYSE TMO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2018$2.66N/AView Earnings Details
4/25/2018Q1 2018$2.42$2.50$5.6230 billion$5.8530 billionViewN/AView Earnings Details
1/31/2018Q4 2017$2.66$2.79$5.7171 billion$6.0470 billionViewListenView Earnings Details
10/25/2017Q3 2017$2.24$2.31$5.0285 billion$5.1162 billionViewN/AView Earnings Details
7/26/2017Q2 2017$2.27$2.30$4.9225 billion$4.9990 billionViewN/AView Earnings Details
4/26/2017Q1 2017$2.0230$2.08$4.6774 billion$4.7650 billionViewN/AView Earnings Details
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
10/27/2010Q3 2010$0.83$0.90ViewN/AView Earnings Details
7/27/2010Q2 2010$0.84$0.84ViewN/AView Earnings Details
4/28/2010Q1 2010$0.75$0.84ViewN/AView Earnings Details
2/3/2010Q4 2009$0.88$0.91ViewN/AView Earnings Details
10/22/2009Q3 2009$0.76$0.78ViewN/AView Earnings Details
7/23/2009Q2 2009$0.67$0.74ViewN/AView Earnings Details
4/23/2009Q1 2009$0.70$0.62ViewN/AView Earnings Details
2/4/2009Q4 2008$0.83$0.88ViewN/AView Earnings Details
10/23/2008Q3 2008$0.76$0.76ViewN/AView Earnings Details
7/24/2008Q2 2008$0.77$0.79ViewN/AView Earnings Details
4/24/2008Q1 2008$0.72$0.74ViewN/AView Earnings Details
2/6/2008Q4 2007$0.69$0.76ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Thermo Fisher Scientific (NYSE:TMO) Dividend Information

Thermo Fisher Scientific pays an annual dividend of $0.68 per share, with a dividend yield of 0.32%. TMO's most recent quarterly dividend payment was Monday, April 16. Thermo Fisher Scientific pays out 7.17% of its earnings out as a dividend.
Most Recent Dividend:4/16/2018
Annual Dividend:$0.68
Dividend Yield:0.32%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio(s):7.17% (Trailing 12 Months of Earnings)
6.23% (Based on This Year's Estimates)
5.61% (Based on Next Year's Estimates)
4.69% (Based on Cash Flow)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE:TMO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/31/2018quarterly$0.170.33%3/14/20183/15/20184/16/2018
11/9/2017quarterly$0.150.32%12/14/201712/15/20171/15/2018
7/12/2017quarterly$0.150.33%9/14/20179/15/201710/16/2017
5/18/2017quarterly$0.150.35%6/13/20176/15/20177/17/2017
2/28/2017quarterly$0.150.38%3/13/20173/15/20174/17/2017
11/10/2016quarterly$0.150.4%12/13/201612/15/20161/16/2017
7/7/2016quarterly$0.150.39%9/13/20169/15/201610/17/2016
5/18/2016quarterly$0.150.4%6/13/20166/15/20167/15/2016
2/25/2016quarterly$0.150.46%3/11/20163/15/20164/15/2016
11/12/2015quarterly$0.150.45%12/11/201512/15/20151/15/2016
7/10/2015quarterly$0.150.45%9/11/20159/15/201510/15/2015
5/21/2015quarterly$0.150.45%6/11/20156/15/20157/15/2015
2/26/2015quarterly$0.150.46%3/12/20153/16/20154/15/2015
11/7/2014quarterly$0.150.51%12/11/201412/15/20141/15/2015
7/10/2014quarterly$0.150.51%9/11/20149/15/201410/15/2014
5/21/2014quarterly$0.156/12/20146/16/20147/15/2014
2/27/2014quarterly$0.150.48%3/13/20143/17/20144/15/2014
11/8/2013quarterly$0.150.61%12/12/201312/16/20131/15/2014
7/12/2013quarterly$0.150.68%9/12/20139/16/201310/15/2013
5/23/2013quarterly$0.150.69%6/13/20136/17/20137/15/2013
2/27/2013quarterly$0.150.81%3/13/20133/15/20134/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Thermo Fisher Scientific (NYSE TMO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.49%
Institutional Ownership Percentage: 86.52%
Insider Trading History for Thermo Fisher Scientific (NYSE:TMO)
Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE TMO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2018Marc N CasperCEOSell40,000$210.16$8,406,400.00334,622View SEC Filing  
3/5/2018Stephen WilliamsonCFOSell2,500$204.60$511,500.00View SEC Filing  
2/23/2018William G ParrettDirectorSell1,000$211.43$211,430.0011,660View SEC Filing  
2/15/2018William G ParrettDirectorSell1,000$209.80$209,800.00View SEC Filing  
2/7/2018Stephen WilliamsonCFOSell5,000$209.26$1,046,300.0030,741View SEC Filing  
2/5/2018Patrick M DurbinInsiderSell6,000$217.55$1,305,300.00View SEC Filing  
2/2/2018Gregory J HerremaSVPSell33,327$219.70$7,321,941.9060,471View SEC Filing  
12/15/2017Marc N CasperCEOSell50,000$191.74$9,587,000.00302,577View SEC Filing  
11/15/2017Marc N CasperCEOSell50,000$188.39$9,419,500.00252,577View SEC Filing  
9/5/2017Peter E HornstraVPSell3,894$185.18$721,090.9219,751View SEC Filing  
8/30/2017C Martin HarrisDirectorSell360$180.97$65,149.205,312View SEC Filing  
8/30/2017Daniel P ShineInsiderSell2,026$180.97$366,645.2220,682View SEC Filing  
8/28/2017Seth H HoogasianVPSell4,140$177.80$736,092.0025,518View SEC Filing  
8/18/2017Jim P ManziDirectorSell11,318$172.94$1,957,334.9238,757View SEC Filing  
8/17/2017Jim P ManziDirectorSell1,000$175.20$175,200.0038,757View SEC Filing  
8/2/2017Gregory J HerremaSVPSell30,000$176.02$5,280,600.0067,016View SEC Filing  
6/5/2017Stephen WilliamsonCFOSell2,500$176.26$440,650.0037,790View SEC Filing  
6/1/2017Marc N CasperCEOSell20,000$172.79$3,455,800.00269,279View SEC Filing  
5/24/2017Daniel P ShineInsiderSell4,688$171.88$805,773.4429,200View SEC Filing  
4/27/2017Thomas W LoewaldInsiderSell1,532$168.76$258,540.3241,277View SEC Filing  
3/15/2017Marc N CasperCEOSell20,000$158.60$3,172,000.00289,279View SEC Filing  
3/15/2017Peter M WilverVPSell9,079$160.73$1,459,267.6762,517View SEC Filing  
3/10/2017Peter M WilverVPSell9,987$158.18$1,579,743.6677,233View SEC Filing  
3/8/2017Thomas W LoewaldInsiderSell7,675$157.39$1,207,968.2550,484View SEC Filing  
3/6/2017Seth H HoogasianVPSell3,142$158.71$498,666.8231,104View SEC Filing  
3/6/2017Stephen WilliamsonCFOSell2,500$158.71$396,775.0040,290View SEC Filing  
3/6/2017Thomas W LoewaldSVPSell4,049$158.71$642,616.7942,809View SEC Filing  
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97307,444View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00308,647View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.7217,437View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.6027,384View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.6835,814View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.9639,983View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.0031,914View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.704,648View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.0052,194View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00340,998View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00350,998View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.0028,779View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.0064,727View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.0038,733View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.0049,169View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.0021,246View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.0027,892View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.0046,937View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.0038,548View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.0028,016View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00350,998View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.2565,136View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.0062,732View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.0085,790View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.0047,794View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.0036,937View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.0045,821View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.0016,944View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.3431,438View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.0014,636View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.0045,821View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.0033,415View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.854,038View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.5038,870View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00360,607View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.3545,821View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.0040,997View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.1241,307View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00101,030View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40125,710View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.5046,159View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.4819,242View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50229,730View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37104,305View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.8840,483View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.0011,188View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00138,360View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00143,785View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Thermo Fisher Scientific (NYSE TMO) News Headlines

Source:
DateHeadline
MTS Systems (MTSC) & Thermo Fisher Scientific (TMO) Head to Head AnalysisMTS Systems (MTSC) & Thermo Fisher Scientific (TMO) Head to Head Analysis
www.americanbankingnews.com - May 17 at 5:11 PM
Thermo Fisher Scientific (TMO) Rating Increased to Buy at Zacks Investment ResearchThermo Fisher Scientific (TMO) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 17 at 3:09 PM
$5.91 Billion in Sales Expected for Thermo Fisher Scientific (TMO) This Quarter$5.91 Billion in Sales Expected for Thermo Fisher Scientific (TMO) This Quarter
www.americanbankingnews.com - May 17 at 2:52 AM
Thermo Fisher Scientific (TMO) Downgraded to Hold at Zacks Investment ResearchThermo Fisher Scientific (TMO) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - May 16 at 1:35 PM
Soros adds to stakes in Aetna, Baxter and Thermo FisherSoros adds to stakes in Aetna, Baxter and Thermo Fisher
seekingalpha.com - May 16 at 9:58 AM
[$$] Lawmakers Say U.S. Tech Is Being Used in Abusive Chinese Crackdowns[$$] Lawmakers Say U.S. Tech Is Being Used in Abusive Chinese Crackdowns
finance.yahoo.com - May 16 at 9:57 AM
$2.69 EPS Expected for Thermo Fisher Scientific (TMO) This Quarter$2.69 EPS Expected for Thermo Fisher Scientific (TMO) This Quarter
www.americanbankingnews.com - May 15 at 3:31 PM
Should You Buy Thermo Fisher Scientific Inc (NYSE:TMO) At This PE Ratio?Should You Buy Thermo Fisher Scientific Inc (NYSE:TMO) At This PE Ratio?
finance.yahoo.com - May 15 at 9:53 AM
Thermo Fisher Scientific (TMO) Given Average Recommendation of "Buy" by BrokeragesThermo Fisher Scientific (TMO) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 14 at 1:30 AM
Financial Contrast: Sierra Monitor (SRMC) versus Thermo Fisher Scientific (TMO)Financial Contrast: Sierra Monitor (SRMC) versus Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - May 13 at 5:38 AM
Head-To-Head Contrast: Image Sensing Systems (ISNS) & Thermo Fisher Scientific (TMO)Head-To-Head Contrast: Image Sensing Systems (ISNS) & Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - May 12 at 11:06 AM
Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2018 Health Care Conference on May 16, 2018Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2018 Health Care Conference on May 16, 2018
finance.yahoo.com - May 9 at 9:24 AM
At $210.07, Is It Time To Buy Thermo Fisher Scientific Inc (NYSE:TMO)?At $210.07, Is It Time To Buy Thermo Fisher Scientific Inc (NYSE:TMO)?
finance.yahoo.com - May 8 at 9:23 AM
Phononic Solid-State Refrigeration and Freezer Technology for Life Sciences and Healthcare Now Available ...Phononic Solid-State Refrigeration and Freezer Technology for Life Sciences and Healthcare Now Available ...
www.businesswire.com - May 4 at 4:37 PM
New Product Launches Drive ABT’s Medical Device BusinessNew Product Launches Drive ABT’s Medical Device Business
finance.yahoo.com - May 4 at 9:17 AM
Durhams Phononic signs exclusive deal with Thermo FisherDurham's Phononic signs exclusive deal with Thermo Fisher
www.bizjournals.com - May 3 at 4:31 PM
BRIEF-Thermo Fisher Scientific Signs New Agreements To Expand Oncomine Dx Target TestBRIEF-Thermo Fisher Scientific Signs New Agreements To Expand Oncomine Dx Target Test
www.reuters.com - May 3 at 4:31 PM
Durham’s Phononic signs exclusive deal with Thermo FisherDurham’s Phononic signs exclusive deal with Thermo Fisher
finance.yahoo.com - May 3 at 9:17 AM
Thermo Fisher debuts new protein expression system for vaccine developersThermo Fisher debuts new protein expression system for vaccine developers
seekingalpha.com - May 2 at 9:17 AM
Thermo Fisher Scientific to Host Analyst MeetingThermo Fisher Scientific to Host Analyst Meeting
finance.yahoo.com - April 30 at 4:34 PM
Thermo Fisher Scientific (TMO) Lifted to "Buy" at Zacks Investment ResearchThermo Fisher Scientific (TMO) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 30 at 9:54 AM
Thermo Fisher Scientific (TMO) Expected to Announce Quarterly Sales of $5.90 BillionThermo Fisher Scientific (TMO) Expected to Announce Quarterly Sales of $5.90 Billion
www.americanbankingnews.com - April 30 at 6:52 AM
Thermo Fisher Scientific (TMO) to Post Q2 2018 Earnings of $2.71 Per Share, Jefferies Group ForecastsThermo Fisher Scientific (TMO) to Post Q2 2018 Earnings of $2.71 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - April 30 at 1:22 AM
Equities Analysts Offer Predictions for Thermo Fisher Scientifics Q2 2018 Earnings (TMO)Equities Analysts Offer Predictions for Thermo Fisher Scientific's Q2 2018 Earnings (TMO)
www.americanbankingnews.com - April 30 at 1:22 AM
Thermo Fisher und Leica entwickeln gemeinsam integrierte Kryo-Tomographie-Workflow-LösungThermo Fisher und Leica entwickeln gemeinsam integrierte Kryo-Tomographie-Workflow-Lösung
www.prnewswire.com - April 28 at 3:33 PM
Zacks: Analysts Expect Thermo Fisher Scientific (TMO) Will Announce Earnings of $2.69 Per ShareZacks: Analysts Expect Thermo Fisher Scientific (TMO) Will Announce Earnings of $2.69 Per Share
www.americanbankingnews.com - April 28 at 3:22 AM
Thermo Fisher Scientific (TMO) PT Raised to $240 at Evercore ISIThermo Fisher Scientific (TMO) PT Raised to $240 at Evercore ISI
www.streetinsider.com - April 27 at 9:53 AM
Thermo Scientific Explorer 4 Additive Scanning Electron Microscope Delivers First Dedicated Solution for 3D Printing ...Thermo Scientific Explorer 4 Additive Scanning Electron Microscope Delivers First Dedicated Solution for 3D Printing ...
www.prnewswire.com - April 27 at 9:53 AM
Thermo Fisher Scientific Inc. 2018 Q1 - Results - Earnings Call SlidesThermo Fisher Scientific Inc. 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - April 27 at 9:53 AM
Analyst Recommendations for TMO Stock after 1Q18 Earnings ReleaseAnalyst Recommendations for TMO Stock after 1Q18 Earnings Release
finance.yahoo.com - April 27 at 9:53 AM
Thermo Fisher Scientific Increases Its Fiscal 2018 GuidanceThermo Fisher Scientific Increases Its Fiscal 2018 Guidance
finance.yahoo.com - April 27 at 9:53 AM
Thermo Fisher Scientific’s 1Q18 Net Income Up 5%, Tops EstimateThermo Fisher Scientific’s 1Q18 Net Income Up 5%, Tops Estimate
finance.yahoo.com - April 26 at 4:33 PM
Thermo Fisher Scientific (TMO) Price Target Raised to $230.00Thermo Fisher Scientific (TMO) Price Target Raised to $230.00
www.americanbankingnews.com - April 26 at 12:17 PM
Thermo Fisher Scientific (TMO) Q1 2018 Results - Earnings Call TranscriptThermo Fisher Scientific (TMO) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 25 at 4:34 PM
Thermo Fisher (TMO) Q1 Earnings Beat Estimates, 18 View UpThermo Fisher (TMO) Q1 Earnings Beat Estimates, '18 View Up
finance.yahoo.com - April 25 at 4:34 PM
Thermo Fisher Scientific (TMO) Posts  Earnings Results, Beats Expectations By $0.08 EPSThermo Fisher Scientific (TMO) Posts Earnings Results, Beats Expectations By $0.08 EPS
www.americanbankingnews.com - April 25 at 11:23 AM
Thermo Fisher Scientific (TMO) Issues FY18 Earnings GuidanceThermo Fisher Scientific (TMO) Issues FY18 Earnings Guidance
www.americanbankingnews.com - April 25 at 9:58 AM
Thermo Fisher Lifts FY18 Forecast, Q1 Results Top Estimates - Quick FactsThermo Fisher Lifts FY18 Forecast, Q1 Results Top Estimates - Quick Facts
www.nasdaq.com - April 25 at 9:52 AM
Thermo Fisher raises 2018 forecast; first quarter profit beatsThermo Fisher raises 2018 forecast; first quarter profit beats
www.reuters.com - April 25 at 9:52 AM
Thermo Fisher Scientific Q1 adjusted earnings Beat EstimatesThermo Fisher Scientific Q1 adjusted earnings Beat Estimates
www.nasdaq.com - April 25 at 9:52 AM
Thermo Fisher Scientific profit up; lifts guidanceThermo Fisher Scientific profit up; lifts guidance
www.marketwatch.com - April 25 at 9:52 AM
Thermo Fisher Q1 revenues up 23%; non-GAAP EPS up 20%; raises 2018 guidanceThermo Fisher Q1 revenues up 23%; non-GAAP EPS up 20%; raises 2018 guidance
seekingalpha.com - April 25 at 9:52 AM
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 10c, Beats on Revenues; Boosts FY18 EPS/Revenue GuidanceThermo Fisher Scientific (TMO) Tops Q1 EPS by 10c, Beats on Revenues; Boosts FY18 EPS/Revenue Guidance
www.streetinsider.com - April 25 at 9:52 AM
Thermo Fisher (TMO) Beats on Q1 Earnings & Sales EstimatesThermo Fisher (TMO) Beats on Q1 Earnings & Sales Estimates
finance.yahoo.com - April 25 at 9:52 AM
Thermo Fisher Scientific Reports First Quarter 2018 ResultsThermo Fisher Scientific Reports First Quarter 2018 Results
www.prnewswire.com - April 25 at 6:34 AM
Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics CapabilitiesThermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities
www.prnewswire.com - April 23 at 4:29 PM
Thermo Fisher Scientific: A Quality Company Trading At A Quality PriceThermo Fisher Scientific: A Quality Company Trading At A Quality Price
seekingalpha.com - April 23 at 9:42 AM
Thermo Fisher Scientific (TMO) Upgraded by BidaskClub to "Strong-Buy"Thermo Fisher Scientific (TMO) Upgraded by BidaskClub to "Strong-Buy"
www.americanbankingnews.com - April 19 at 12:49 PM
Thermo Fisher Scientific (TMO) Given Consensus Recommendation of "Buy" by AnalystsThermo Fisher Scientific (TMO) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - April 19 at 1:36 AM
Thermo Fisher Scientific (TMO) Set to Announce Earnings on WednesdayThermo Fisher Scientific (TMO) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - April 18 at 2:30 AM

SEC Filings

Thermo Fisher Scientific (NYSE:TMO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Thermo Fisher Scientific (NYSE:TMO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Thermo Fisher Scientific (NYSE TMO) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.